Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6314178rdf:typepubmed:Citationlld:pubmed
pubmed-article:6314178lifeskim:mentionsumls-concept:C0031117lld:lifeskim
pubmed-article:6314178lifeskim:mentionsumls-concept:C0020861lld:lifeskim
pubmed-article:6314178lifeskim:mentionsumls-concept:C0129439lld:lifeskim
pubmed-article:6314178lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:6314178lifeskim:mentionsumls-concept:C0443737lld:lifeskim
pubmed-article:6314178lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:6314178lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:6314178pubmed:issue11lld:pubmed
pubmed-article:6314178pubmed:dateCreated1983-12-17lld:pubmed
pubmed-article:6314178pubmed:abstractTextThree patients with a monoclonal IgM kappa paraproteinemia had a slowly progressive segmental demyelinating peripheral neuropathy. Sural nerve biopsies showed predominantly large fiber loss, with widening of the intraperiod line of myelin associated with active demyelination. Immunoblot analysis showed reactivity of IgM to myelin-associated glycoprotein (MAG) of human myelin. An enzyme-linked immunosorbent assay (ELISA) was developed to provide a simple quantitative technique for detection of antibodies to MAG. Treatment with corticosteroids, immunosuppressive agents, and plasmapheresis produced no significant improvement.lld:pubmed
pubmed-article:6314178pubmed:languageenglld:pubmed
pubmed-article:6314178pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6314178pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6314178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6314178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6314178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6314178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6314178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6314178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6314178pubmed:statusMEDLINElld:pubmed
pubmed-article:6314178pubmed:monthNovlld:pubmed
pubmed-article:6314178pubmed:issn0028-3878lld:pubmed
pubmed-article:6314178pubmed:authorpubmed-author:StewartJJlld:pubmed
pubmed-article:6314178pubmed:authorpubmed-author:DuncanIIlld:pubmed
pubmed-article:6314178pubmed:authorpubmed-author:FinlaysonMMlld:pubmed
pubmed-article:6314178pubmed:authorpubmed-author:BraunPPlld:pubmed
pubmed-article:6314178pubmed:authorpubmed-author:MelmedCClld:pubmed
pubmed-article:6314178pubmed:authorpubmed-author:DanoffDDlld:pubmed
pubmed-article:6314178pubmed:authorpubmed-author:FrailDDlld:pubmed
pubmed-article:6314178pubmed:issnTypePrintlld:pubmed
pubmed-article:6314178pubmed:volume33lld:pubmed
pubmed-article:6314178pubmed:ownerNLMlld:pubmed
pubmed-article:6314178pubmed:authorsCompleteYlld:pubmed
pubmed-article:6314178pubmed:pagination1397-405lld:pubmed
pubmed-article:6314178pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:meshHeadingpubmed-meshheading:6314178-...lld:pubmed
pubmed-article:6314178pubmed:year1983lld:pubmed
pubmed-article:6314178pubmed:articleTitlePeripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein.lld:pubmed
pubmed-article:6314178pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6314178pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6314178lld:pubmed